Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system

被引:392
作者
Gao, Lei [1 ]
Zhang, Dianrui [1 ]
Chen, Minghui [2 ]
机构
[1] Shandong Univ, Dept Pharmaceut, Coll Pharm, Jinan 250012, Peoples R China
[2] Shandong Univ, Dept Pharmacol, Coll Pharm, Jinan 250012, Peoples R China
关键词
poorly soluble drugs; nanocrystals; bioavailability; precipitation; pearl milling; high-pressure homogenization; colloids; nanomedicine;
D O I
10.1007/s11051-008-9357-4
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Formulation of poorly soluble drugs is a general intractable problem in pharmaceutical field, especially those compounds poorly soluble in both aqueous and organic media. It is difficult to resolve this problem using conventional formulation approaches, so many drugs are abandoned early in discovery. Nanocrystals, a new carrier-free colloidal drug delivery system with a particle size ranging from 100 to 1000 nm, is thought as a viable drug delivery strategy to develop the poorly soluble drugs, because of their simplicity in preparation and general applicability. In this article, the product techniques of the nanocrystals were reviewed and compared, the special features of drug nanocrystals were discussed. The researches on the application of the drug nanocrystals to various administration routes were described in detail. In addition, as introduced later, the nanocrystals could be easily scaled up, which was the prerequisite to the development of a delivery system as a market product.
引用
收藏
页码:845 / 862
页数:18
相关论文
共 59 条
[1]
Liposomes - Opportunities in drug delivery [J].
Allen, TM .
DRUGS, 1997, 54 (Suppl 4) :8-14
[2]
Numerical simulation of milling processes as an aid to process design [J].
Annapragada, A ;
Adjei, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 136 (1-2) :1-11
[3]
[Anonymous], [No title captured]
[4]
Blunk T, 1996, EUR J PHARM BIOPHARM, V42, P262
[5]
Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs [J].
Böhm, BHL ;
Müller, RH .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (08) :336-339
[6]
HPLC determination of clofazimine in tissues and serum of mice after intravenous administration of nanocrystalline or liposomal formulations [J].
Borner, K ;
Hartwig, H ;
Leitzke, S ;
Hahn, H ;
Müller, RH ;
Ehlers, S .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 11 (01) :75-79
[7]
Role of polymeric stabilizers for drug nanocrystal dispersions [J].
Choi, JY ;
Yoo, JY ;
Kwak, HS ;
Nam, BU ;
Lee, J .
CURRENT APPLIED PHYSICS, 2005, 5 (05) :472-474
[8]
Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique [J].
Douroumis, D. ;
Fahr, A. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 63 (02) :173-175
[9]
Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms [J].
Dressman, JB ;
Amidon, GL ;
Reppas, C ;
Shah, VP .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :11-22
[10]
Model of the evolution of nanoparticles to crystals via an aggregative growth mechanism [J].
Drews, Timothy O. ;
Tsapatsis, Michael .
MICROPOROUS AND MESOPOROUS MATERIALS, 2007, 101 (1-2) :97-107